Welcome to our dedicated page for Healthcare Triangle news (Ticker: HCTI), a resource for investors and traders seeking the latest updates and insights on Healthcare Triangle stock.
Healthcare Triangle, Inc. (Nasdaq: HCTI) generates a steady flow of news related to healthcare information technology, digital transformation, and AI-driven health platforms. Based in Pleasanton, California, the company reports on developments that span cloud and data platforms, acquisitions, financing activities, and the evolution of its digital health ecosystem.
News about Healthcare Triangle frequently highlights its role as a provider of digital transformation solutions for hospitals and health systems, payers, and pharma/life sciences organizations. Coverage often references its HITRUST-certified Cloud and Data Platform (CloudEz™ and DataEz™), as well as its work in security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
Recent company communications emphasize a strategic shift toward AI-powered digital health. Articles and press releases discuss the GenAI-powered QuantumNexis platform, the Ezovion EMR and hospital information system, and digital mental health and engagement tools such as Ziloy. News items also describe milestones like Ezovion processing significant volumes of revenue for healthcare providers and plans to launch an integrated payment gateway to create transaction-based revenue streams.
Investors following HCTI news will also see updates on mergers and acquisitions and capital structure decisions. The company has announced an Asset Transfer Agreement involving Niyama Healthcare and Ezovion Solutions, and it has disclosed a non-binding Letter of Intent and an Advance Agreement related to acquiring AI-powered customer engagement businesses associated with Teyame.AI, Teyame 360 SL, and Datono Mediacion SL. Additional news covers warrant inducement transactions, convertible note financings, and at-the-market equity programs.
This news page aggregates these disclosures, sponsored articles, and regulatory announcements so readers can track Healthcare Triangle’s progress in AI-driven healthcare technology, its expansion of SaaS and fintech-enabled platforms, and its ongoing efforts to maintain Nasdaq listing compliance and support growth through capital markets activity.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis launched Dubai operations in Meydan Free Zone on Feb 27, 2026 to deliver clinically validated digital mental health solutions and an AI-powered Hospital Information System across GCC markets.
The expansion emphasizes national interoperability (openEHR), Microsoft and Better.care partnerships, and alignment with UAE NABIDH/Riayati and Saudi Vision 2030. Market notes: UAE digital health projected at USD 1.84B by 2030 and Saudi at over USD 11B by 2033.
Healthcare Triangle (Nasdaq: HCTI) entered definitive agreements for a registered direct offering of 681,553 shares (or prefunded warrants) at $5.81 per share, expected to close on or about February 27, 2026. Gross proceeds are expected to be approximately $3.959 million before fees and expenses. D. Boral Capital is sole placement agent. The offering is made under an existing Form S-3 shelf registration declared effective January 31, 2024; a prospectus supplement will be filed with the SEC.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis announced a strategic partnership with TNG Digital on Feb 25, 2026 to embed clinically validated digital mental health services into TNG eWallet for over 25 million Malaysian users.
The integration will deliver in-app assessments, licensed professional access, multilingual support, and a transaction-based revenue model with expected meaningful adoption in 6–12 months.
Healthcare Triangle (Nasdaq: HCTI) will effect a 1-for-60 reverse stock split effective 12:01 a.m. ET on February 10, 2026, with post-split trading on Nasdaq at market open February 10, 2026, pending DTC and Nasdaq confirmations.
The split was approved by stockholders on February 2, 2026, assigns new CUSIP 42227W405, reduces outstanding shares from ~45,417,091 to ~756,952, and is intended to help the company regain compliance with Nasdaq's $1.00 minimum bid price. Stockholders of record as of January 8, 2026 will receive post-split information from transfer agent VStock Transfer.
Healthcare Triangle (Nasdaq: HCTI) subsidiary QuantumNexis announced a joint venture with Golden Code Holdings to accelerate AI and digital health transformation in Saudi Arabia, targeting the $70 billion Saudi healthcare market by 2030. The JV will deploy interoperable, open‑standards platforms (Ezovion, Ziloy.ai, Readabl.ai, openEHR) and partner with Microsoft and Better.care to support Saudi Vision 2030, build local workforce capability, and establish a Middle East hub for innovation, research, and co‑development across hospitals, clinics, and national health programs.
Healthcare Triangle (Nasdaq: HCTI) entered a Development Program Agreement with Better to expand digital health platform services across Europe, Southeast Asia, the Middle East, and Africa. The collaboration gives HCTI and subsidiary QuantumNexis access to training, certification, and partner status to deploy Better's openEHR-based solutions.
The partnership targets market entry in India, Malaysia, Indonesia, the Philippines, Saudi Arabia, and multiple African markets and positions HCTI as a preferred service provider for Better's platform.
Healthcare Triangle (Nasdaq: HCTI) will participate in the Deal Flow Discovery Conference in Atlantic City on January 28-29, 2026 and will present at 3:00 PM on January 28, 2026. The company will showcase its healthcare cloud services, AI data platforms, digital transformation solutions, behavioural health tools, cybersecurity offerings, and international acquisition road map.
HCTI management will hold one-on-one investor meetings to discuss its technology roadmap, market opportunities, and long-term value creation strategy.
Healthcare Triangle (Nasdaq: HCTI) signed a definitive agreement to acquire Spain-based AI CX assets run by Teyame AI, aiming to expand its SaaS footprint in Europe and Latin America.
The deal contemplates up to $50 million in total consideration (cash, common stock, non-voting convertible preferred stock, and contingent earnout equity), targets a closing on Jan 29, 2026 subject to shareholder approval, and is effective Jan 1, 2026 for accounting. The assets reported ~$32M revenue and ~$3.6M EBITDA for FY2025; the company forecasts incremental $38M NTM revenue and $5M NTM EBITDA.
Healthcare Triangle (Nasdaq: HCTI) signed an Advance Agreement to acquire Spain-based AI customer engagement Assets run by Teyame AI, targeting a closing in Q1 2026 subject to a definitive purchase agreement, due diligence, shareholder approval, and customary conditions. The contemplated deal values consideration at up to approximately $50 million in cash, common stock, non-voting convertible preferred stock and contingent earnouts. The company expects the Assets to generate ~$34 million incremental revenue and $4.2 million incremental EBITDA for fiscal year 2025, and to expand HCTI's AI-driven patient engagement and global SaaS strategy.
Healthcare Triangle (NASDAQ:HCTI) announced strategic moves including a planned acquisition of Teyame.AI (a European firm projected to generate $34 million in revenue) and a warrant inducement to tighten capital terms. management says these actions pair HCTI’s HITRUST-certified cloud and data platform with real-time AI capabilities to drive growth. The stock has risen more than 32% since September, trading at $2.87 at Monday's close. The company is described as a $16 million microcap pursuing scale while prioritizing compliance and measurable traction.